Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

South Korea Announces $102 Million Biotech Startup Fund

publication date: Apr 5, 2017
The government of South Korea has announced a $102 million fund to support biotech startups in the country. Already a biopharma center, South Korea wants to augment the industry, hoping to create jobs and boost the economy. The fund was alternately described as building infrastructure, providing money for young biotech entrepreneurs and aiding venture capitalists (probably by starting companies that VCs would support later). South Korea believes that biotech, along with IT, represents the future, and the country wants to participate in its global development. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital